Cargando…

Immunotherapy in metastatic prostate cancer

INTRODUCTION: Prostate cancer remains a challenge as a target for immunological approaches. The approval of the first cell-based immune therapy, Sipuleucel-T for prostate cancer introduced prostate cancer as a solid tumor with the potential to be influenced by the immune system. METHODS: We reviewed...

Descripción completa

Detalles Bibliográficos
Autor principal: Slovin, Susan F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5054656/
https://www.ncbi.nlm.nih.gov/pubmed/27843208
http://dx.doi.org/10.4103/0970-1591.191240

Ejemplares similares